124 related articles for article (PubMed ID: 24036327)
1. PPARγ-dependent pathway in the growth-inhibitory effects of K562 cells by carotenoids in combination with rosiglitazone.
Zhao H; Gu H; Zhang H; Li JH; Zhao WE
Biochim Biophys Acta; 2014 Jan; 1840(1):545-55. PubMed ID: 24036327
[TBL] [Abstract][Full Text] [Related]
2. Evodiamine inhibits the proliferation of leukemia cell line K562 by regulating peroxisome proliferators-activated receptor gamma (PPARγ) pathway.
Sun C; Zhang G; Luan S; Luan C; Shao H; Dong F; Liu X
J Recept Signal Transduct Res; 2016 Aug; 36(4):422-8. PubMed ID: 26671528
[TBL] [Abstract][Full Text] [Related]
3. Carotenoids inhibit proliferation and regulate expression of peroxisome proliferators-activated receptor gamma (PPARγ) in K562 cancer cells.
Zhang X; Zhao WE; Hu L; Zhao L; Huang J
Arch Biochem Biophys; 2011 Aug; 512(1):96-106. PubMed ID: 21620794
[TBL] [Abstract][Full Text] [Related]
4. Thiazolidinediones regulate expression of cell cycle proteins in human prostate cancer cells via PPARgamma-dependent and PPARgamma-independent pathways.
Lyles BE; Akinyeke TO; Moss PE; Stewart LV
Cell Cycle; 2009 Jan; 8(2):268-77. PubMed ID: 19164938
[TBL] [Abstract][Full Text] [Related]
5. Rosiglitazone enhances fluorouracil-induced apoptosis of HT-29 cells by activating peroxisome proliferator-activated receptor gamma.
Zhang YQ; Tang XQ; Sun L; Dong L; Qin Y; Liu HQ; Xia H; Cao JG
World J Gastroenterol; 2007 Mar; 13(10):1534-40. PubMed ID: 17461445
[TBL] [Abstract][Full Text] [Related]
6. A PPARgamma agonist inhibits aldosterone-induced mesangial cell proliferation by blocking ROS-dependent EGFR intracellular signaling.
Yuan Y; Zhang A; Huang S; Ding G; Chen R
Am J Physiol Renal Physiol; 2011 Feb; 300(2):F393-402. PubMed ID: 21123490
[TBL] [Abstract][Full Text] [Related]
7. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
Lin MS; Chen WC; Bai X; Wang YD
J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
[TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone inhibits insulin-like growth factor‑1-induced polycystic kidney disease cell growth and p70S6 kinase activation.
Liu C; Zhang Y; Yuan L; Fu L; Mei C
Mol Med Rep; 2013 Sep; 8(3):861-4. PubMed ID: 23864113
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide.
Sommer M; Wolf G
Am J Nephrol; 2007; 27(4):425-34. PubMed ID: 17622750
[TBL] [Abstract][Full Text] [Related]
10. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
Morosetti R; Servidei T; Mirabella M; Rutella S; Mangiola A; Maira G; Mastrangelo R; Koeffler HP
Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma.
Jung TI; Baek WK; Suh SI; Jang BC; Song DK; Bae JH; Kwon KY; Bae JH; Cha SD; Bae I; Cho CH
Gynecol Oncol; 2005 May; 97(2):365-73. PubMed ID: 15863131
[TBL] [Abstract][Full Text] [Related]
12. Combined effect of honokiol and rosiglitazone on cell growth inhibition through enhanced G0/G1 phase arrest in hepatoma cells.
Chen HC; Hsu HT; Weng JW; Chang YF; Hsia CY; Lee HC; Chi CW
J Chin Med Assoc; 2016 Aug; 79(8):415-21. PubMed ID: 27094504
[TBL] [Abstract][Full Text] [Related]
13. PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms.
Yi JH; Park SW; Brooks N; Lang BT; Vemuganti R
Brain Res; 2008 Dec; 1244():164-72. PubMed ID: 18948087
[TBL] [Abstract][Full Text] [Related]
14. The PPARγ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells.
Moss PE; Lyles BE; Stewart LV
Exp Cell Res; 2010 Dec; 316(20):3478-88. PubMed ID: 20932825
[TBL] [Abstract][Full Text] [Related]
15. Thiazolidinediones/PPARγ agonists and fatty acid synthase inhibitors as an experimental combination therapy for prostate cancer.
Mansour M; Schwartz D; Judd R; Akingbemi B; Braden T; Morrison E; Dennis J; Bartol F; Hazi A; Napier I; Abdel-Mageed AB
Int J Oncol; 2011 Feb; 38(2):537-46. PubMed ID: 21170507
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-γ ligands via Wnt signaling pathway.
Liu JJ; Dai XJ; Xu Y; Liu PQ; Zhang Y; Liu XD; Fang ZG; Lin DJ; Xiao RZ; Huang RW; Huang HQ
Cell Biochem Biophys; 2012 Jan; 62(1):19-27. PubMed ID: 21837368
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone inhibits cell proliferation by inducing G1 cell cycle arrest and apoptosis in ADPKD cyst-lining epithelia cells.
Liu Y; Dai B; Fu L; Jia J; Mei C
Basic Clin Pharmacol Toxicol; 2010 Jun; 106(6):523-30. PubMed ID: 20210794
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone induces autophagy in H295R and cell cycle deregulation in SW13 adrenocortical cancer cells.
Cerquetti L; Sampaoli C; Amendola D; Bucci B; Masuelli L; Marchese R; Misiti S; De Venanzi A; Poggi M; Toscano V; Stigliano A
Exp Cell Res; 2011 Jun; 317(10):1397-410. PubMed ID: 21376716
[TBL] [Abstract][Full Text] [Related]
19. Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
Aiello A; Pandini G; Frasca F; Conte E; Murabito A; Sacco A; Genua M; Vigneri R; Belfiore A
Endocrinology; 2006 Sep; 147(9):4463-75. PubMed ID: 16777971
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of divergent effects of activated peroxisome proliferator-activated receptor-γ on mitochondrial citrate carrier expression in 3T3-L1 fibroblasts and mature adipocytes.
Bonofiglio D; Santoro A; Martello E; Vizza D; Rovito D; Cappello AR; Barone I; Giordano C; Panza S; Catalano S; Iacobazzi V; Dolce V; Andò S
Biochim Biophys Acta; 2013 Jun; 1831(6):1027-36. PubMed ID: 23370576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]